[1]
De Sanctis, V. et al. 2019. Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men. Acta Biomedica Atenei Parmensis. 90, 2 (May 2019), 228–232. DOI:https://doi.org/10.23750/abm.v90i2.8477.